noscript

News and Announcements

Development Update UBI PT-INR Testing System

  • Published October 15, 2015 11:36AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

15th October 2015, ASX Announcement

Universal Biosensors, Inc. (ASX: UBI) today provided the following development update with respect to its own PT-INR testing system to be used in decentralised settings (e.g. doctor’s offices and the home).

The Company is currently undertaking a program of product reliability and performance testing to verify that the system is ready for clinical trials and usability studies.

At the same time it is finalising arrangements with clinical sites in preparation for the start of regulatory clinical trials.

As soon as sufficient clinical data has been collected to demonstrate performance across an appropriate patient population, the Company will be in a position to see CE Mark self-certification and approve the product for initial European release. It is anticipated that this will now occur in the first half of 2016, noting that the majority of the costs of associated product development are expected to be incurred before the end of 2015.

To read the full announcement, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now